Stable correction of a genetic deficiency in human cells by an episome carrying a 115 kb genomic transgene
- 1 December 2000
- journal article
- technical report
- Published by Springer Nature in Nature Biotechnology
- Vol. 18 (12) , 1311-1314
- https://doi.org/10.1038/82444
Abstract
Persistent expression of a transgene at therapeutic levels is required for successful gene therapy, but many small vectors with heterologous promoters are prone to vector loss and transcriptional silencing. The delivery of genomic DNA would enable genes to be transferred as complete loci, including regulatory sequences, introns, and native promoter elements. These elements may be critical to ensure prolonged, regulated, and tissue-specific transgene expression. Many studies point to considerable advantages to be gained by using complete genomic loci in gene expression1,2,3. Large-insert vectors incorporating elements of the bacterial artificial chromosome (BAC) cloning system4, and the episomal maintenance mechanisms of Epstein–Barr virus (EBV), can shuttle between bacteria and mammalian cells, allowing large genomic loci to be manipulated conveniently5. We now demonstrate the potential utility of such vectors by stably correcting a human genetic deficiency in vitro. When the complete hypoxanthine phosphoribosyltransferase (HPRT) locus of 115 kilobases (kb) was introduced into deficient human cells, the transgene was both maintained as an episome and expressed stably for six months in rapidly dividing cell cultures. The results demonstrate for the first time that gene expression from an episomal genomic transgene can correct a cell culture disease phenotype for a prolonged period.Keywords
This publication has 26 references indexed in Scilit:
- BAC-mediated gene-dosage analysis reveals a role for Zipro1 (Ru49/Zfp38) in progenitor cell proliferation in cerebellum and skinNature Genetics, 1999
- Long-term stability of large insert genomic DNA episomal shuttle vectors in human cellsNucleic Acids Research, 1999
- Lipid-Mediated Enhancement of Transfection by a Nonviral Integrin-Targeting VectorHuman Gene Therapy, 1998
- Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicityNature Genetics, 1998
- Homologous recombination based modification in Esherichia coli and germline transmission in transgenic mice of a bacterial artificial chromsomeNature Biotechnology, 1997
- The potential of extrachromosomal replicating vectors for gene therapyTrends in Genetics, 1996
- Stable Episomal Maintenance of Yeast Artificial Chromosomes in Human CellsMolecular and Cellular Biology, 1996
- Influence of PAX6 Gene Dosage on Development: Overexpression Causes Severe Eye AbnormalitiesCell, 1996
- Cloning and stable maintenance of 300-kilobase-pair fragments of human DNA in Escherichia coli using an F-factor-based vector.Proceedings of the National Academy of Sciences, 1992
- The HPRT locusCell, 1979